Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 703-709 , October 2008

Activin-A, Transforming Growth Factor-β, and Myostatin Signaling Pathway in Experimental Dilated Cardiomyopathy

  • Maryam Mahmoudabady, MD

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • Department of Physiology, Ghaem Hospital, Mashad University of Medical Sciences, Mashad, Iran
    • ,
  • Myrielle Mathieu, DVM

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • ,
  • Laurence Dewachter, MSC

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • ,
  • Ielham Hadad, MSC

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • ,
  • Lynn Ray, MSC

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • ,
  • Pascale Jespers, MSC

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • ,
  • Serge Brimioulle, MD, PhD

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • ,
  • Robert Naeije, MD, PhD

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • ,
  • Kathleen McEntee, DVM, PhD

      Affiliations

    • Laboratory of Physiology, Université Libre de Bruxelles, Brussels, Belgium
    • Corresponding Author InformationReprint requests: Kathleen McEntee, DVM, PhD, Université Libre de Bruxelles, Faculty of Medicine, Laboratory of Physiology, CP 604, Lennik Road, 808, 1070 Brussels, Belgium.

Received 15 January 2008 ,Revised 10 April 2008 ,Accepted 9 May 2008.

References 

  1. Van Empel V, De Windt LJ. Myocyte hypertrophy and apoptosis: a balancing act. Review. Cardiovasc Res. 2004;63:487–499
  2. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med Vol. 2002;227:75–87
  3. Attisano L, Wrana JL, Montalvo E, Massagué J. Activation of signaling by the activin receptor complex. Mol Cell Biol. 1996;16:1066–1073
  4. Chen YG, Wang Q, Lin SL, Chang CD, Chung J, Ying SY. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp Biol Med. 2006;231:5324–5544
  5. Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002;296:1646–1647
  6. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A. 2001;98:9306–9311
  7. Tsuchida K, Matsuzaki T, Yamakawa N, Liu Z, Sugino H. Intracellular and extracellular control of activin function by novel regulatory molecules. Mol Cell Endocrinol. 2001;180:25–31
  8. Sherr CJ. Mammalian G1 cyclins. Cell. 1993;73:1059–1065
  9. Tamamori M, Ito H, Hiroe M, Terada Y, Marumo F, Ikeda M-A. Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am J Physiol. 1998;275:H2036–H2040
  10. Sharma M, Kambadur R, Matthews KG, Somersd WG, Delvin GP, Conaglen JV, et al. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol. 1999;180:1–9
  11. Shyu KG, Lu MJ, Wang BW, Sun HY, Chang H. Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Eur J Clin Invest. 2006;36:713–719
  12. Morissette MR, Cook SA, Foo S, McKoy G, Ashida N, Novikov M, et al. Myostatin regulates cardiomyocytes growth through modulation of Akt signaling. Circ Res. 2006;99:15–24
  13. Yndestad A, Ueland T, Oie E, Florholmen G, Halvorsen B, Attramadal H, et al. Elevated levels of activin A in heart failure potential role in myocardial remodeling. Circulation. 2004;109:1379–1385
  14. Florholmen G, Halvorsen B, Beraki K, Lyberg T, Sagen EL, Aukrust P, et al. Activin A inhibits organisation of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor. J Mol Cell Cardiol. 2006;41:689–697
  15. Motte S, van Beneden R, Mottet J, Rondelet B, Mathieu M, Havaux X, et al. Early activation of cardiac and renal endothelin systems in experimental heart failure. Am J Physiol Heart Circ Physiol. 2003;285:H2482–H2491
  16. Motte S, Mathieu M, Brimioulle S, Pensis A, Ray L, Ketelslegers JM, et al. Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol. 2005;289:H1729–H1735
  17. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation. 1978;58:1072–1083
  18. Thomas WP, Gaber CE, Jacobs GJ, Kapla PM, Lombard CW, Moise NS, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and the cat. J Vet Int Med. 1993;7:247–252
  19. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976;37:7–11
  20. Schiller NB, Skioldebrand CG, Schiller EJ, Mavroudis CC, Silverman NH, Rahimtoola SH, et al. Canine left ventricular mass estimation by two-dimensional echocardiography. Circulation. 1983;68:210–216
  21. Winer J, Jnug CK, Shackel I, Williams PL. Development and validation of real-time quantitative reverse transcription-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999;270:41–49
  22. Poon CS. Analysis of linear and mildly nonlinear relationships using pooled subject data. J Appl Physiol. 1988;64:854–859
  23. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signaling. Nature. 1997;389:631–635
  24. Matzusaki T, Hanai S, Kishi H, Liu ZH, Ba OY, Kikuchi A, et al. Regulation of endocytosis of activin type II receptors by an novel PDZ protein through Aal/Ral-binding protein 1-dependent pathway. J Biol Chem. 2002;277:19008–19018
  25. Shoji H, Tsuchida K, Kishi H, Yamakawa N, Matsuzaki T, Liu ZH, et al. Identification and characterization of a PDZ protein that interacts with activin type II receptors. J Biol Chem. 2000;275:5485–5492
  26. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci. 1995;92:5545–5549
  27. Pardali K, Kowanetz M, Heldin CH, Moustakas A. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21 (WAF1/Cip1). J Cell Physiol. 2005;204:260–272
  28. Brooks G, Poolman RA, Li J-M. Arresting developments in the cardiac myocyte cycle: role of cyclin-dependent kinase inhibitors. Cardiovasc Res. 1998;39:301–311
  29. Li J-M, Brooks G. Downregulation of the cyclin-dependent kinase inhibitors, p21 and p27, in pressure overload hypertrophy. Am J Physiol. 1997;273:H1358–H1367
  30. Nozato T, Ito H, Tamamori M, Adachi S, Abe S, Marumo F, et al. G1 cyclins are invlolved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II. Jpn Circ J. 2000;64:595–601
  31. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83–90
  32. Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR. Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromusc Disord. 2007;17:290–296
  33. Cook SA, Matsui T, Li L, Bosenzweig A. Transcriptional effects of chronic Akt activation in the heart. J Biol Chem. 2002;277:22528–22533

 This work was supported by the Foundation for Cardiac Surgery, Belgium. Maryam Mahmoudabady has a grant from the Ministry of Health and Medical Education, Iran.

PII: S1071-9164(08)00167-X

doi: 10.1016/j.cardfail.2008.05.003

Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 703-709 , October 2008

Article Tools

* Image Usage & Resolution